Secondary genomic analysis of the phase 3 zoliflodacin gonorrhoea trial: 5 of 22 (23%) zoliflodacin microbiological failures had different strains at test of cure, suggesting reinfection; 59% had no clear explanation, and no isolate showed resistance selection.
RCTn = 960 isolates
Unemo et al. Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study